ChiCTR1800014890
正在进行
/
/
/
2018-02-07
/
/
慢性肌骼痛症
長者慢性肌骼痛症運動治療研究計劃
長者慢性肌骼痛症運動治療研究計劃
長者慢性肌骼痛症運動治療研究計劃
随机平行对照
其它
1:1 randomization
Open label
Health Care and Promotion Scheme, Food and Health Bureau, The Government of SAR
/
72
/
1990-01-01
1990-01-01
/
(i) community-dwelling older adults (age ≥65 years); and (ii) mobile over 10m with or without a walking aid; (iii) present of chronic musculoskeletal pain over the past month and for at least 3 month of the previous year; (iv) pain intensity score ≥ 3 on a numerical rating scale of 10; (v) stable baseline activity; (vi) able to understand written and verbal Chinese.；
请登录查看(i) dementia or mild cognitive impairment (including those showing any signs of cognitive impairment as advised by the scheme manager/medical records); (ii) MSK pain due to uncontrolled rheumatic disease ; (iii) a recent self-reported history of stroke or major surgery (in the past 6 months); (iv) terminally ill; (v) has a serious mental illness; (vi) comorbid conditions which might interfere with the participant's active participation in the study; (vii) severe or uncontrolled heart disease; (viii) participants with major joint replacement or spinal surgery; and (ix) participants who fulfil the diagnostic criteria of Chronic Fatigue Syndrome (CFS) by the Center of Disease Control, which is a debilitating and complex disorder characterized by intense fatigue, which worsens with physical and mental exertion, with widespread pain as one of its presentations.；
请登录查看The Chinese University Of Hong Kong
/
MedTrend医趋势2026-02-21
肝脏时间2026-02-21
新通药物2026-02-21
数字医疗2026-02-21
医药笔记2026-02-21
医药笔记2026-02-21
医药笔记2026-02-21
药明康德2026-02-21
基石药业官微2026-02-16
一度医药2026-02-16
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
